MIRACUM Konsortium

What MIRACUM Konsortium does

MIRACUM Konsortium (Medical Informatics in Research and Medicine) is one of four consortia within the German Medical Informatics Initiative (MII), established in 2016 and headquartered in Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU). The consortium builds and operates Data Integration Centers (DIZ) at 17 German university hospitals that harmonize routine patient care data into privacy-compliant, interoperable formats (HL7 FHIR, i2b2, OMOP) and make that data accessible across sites through the national Forschungsdatenportal für Gesundheit (FDPG). Through FDPG, MIRACUM-affiliated infrastructure provides access to over 2 billion laboratory values, data from more than 21 million patients, and over 200 million intensive-care vital data points.

The technical stack centers on federated data infrastructure rather than centralized warehousing: the 17 DIZ act as decentralized harmonization hubs, FLAME provides federated analysis without moving sensitive patient data, and core tooling includes MIRACOLIX-Tools (data integration suite), GeMTeX (semantic annotation of clinical text), and ProSkive. MIRACUM also operates four Digital Progress Hubs (DECIDE, LeMeDaRT, MIDIA-Hub, MiHUBx) that translate university-developed digital health solutions into regional hospitals and outpatient settings, and runs six dedicated junior research groups (AI-RON, EkoEstMed, MeDaX, MIDorAI, ProModell, plus one additional) covering AI in neuro-oncology imaging, precision medicine, and digital twins of the human body.

MIRACUM is a publicly funded research consortium with no commercial revenue. All funding flows from the German Federal Ministry of Education and Research (BMBF/BMFTR) — over €200 million in the initial 2018-2022 phase, ~€200 million in the 2023-2026 expansion phase, ~€50 million for Digital Progress Hubs (2021-2025), and ~€30 million for 21 junior research groups (2020-2026). Member institutions contribute additional in-kind resources. Services — DIZ access, FDPG portal use, the Master BIDS program, MIRACUM Schools — are provided free of charge to university-affiliated researchers and clinicians. The operational "customers" are the 17 university hospital DIZ sites and the broader medical research community, while the sole funder is the German federal government.

Name

MIRACUM Konsortium

Legal name

MIRACUM Konsortium

Website

https://miracum.org

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

MIRACUM Konsortium is a German federally-funded research consortium within the Medical Informatics Initiative, operating Data Integration Centers at university hospitals to enable federated, privacy-compliant access to clinical data for medical researchers via the national FDPG portal.

Ownership category

akta.pro rank

Product category

Medical Informatics Research Infrastructure

NAICS

Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

akta.pro secondary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

• Medical informatics
• Clinical data integration
• Federated research infrastructure
• Healthcare AI research
• University hospital networks

Headquarters

HQ city

Erlangen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. BMBF Federal Funding: MIRACUM is fully funded by the German Federal Ministry of Education and Research (BMBF) as part of the Medical Informatics Initiative (MII). Initial funding phase 2018-2022 exceeded €200 million for DIZ establishment. The expansion phase 2023-2026 receives additional BMBF funding. Digital Progress Hubs receive ~€50 million and junior research groups ~€30 million.
2. Institutional / Partnership Resources: Consortium members contribute resources from their own institutional budgets, particularly university hospitals and partner universities (FAU Erlangen-Nürnberg, TUM, and others). No commercial revenue generation.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels12 records

Core offering

MIRACUM operates and coordinates a federated research-data infrastructure for German university medicine, built around site-level Data Integration Centers (DIZ) that make routine clinical data from approximately 21.4 million patients findable, accessible, interoperable and reusable for approved medical research. It delivers software tools (MIRACOLIX-Tools), AI and digital-twin research outputs, Digital Progress Hubs that translate findings into clinical routine, a national FDPG research portal, and a Master's / schools education track that trains the workforce to use the infrastructure.

Product overview

MIRACUM is a consortium within Germany's Medical Informatics Initiative (MII) funded by the BMBF. The core offering consists of Data Integration Centers (DIZ) at university hospitals that provide federated access to clinical data via the national German Research Data Portal for Health (FDPG). The consortium developed a research portal (closed 2023 to consolidate on FDPG) and supports Digital Progress Hubs (MIDIA-Hub, DECIDE, LeMeDaRT, MiHUBx) that extend MII infrastructure into regional healthcare. Education products include a Master's program in Biomedical Informatics and Data Science, MIRACOLIX-Tools for data management, MIRACUM Schools (Summer/Winter Schools), and the ONE MII Journal. Research groups like AI-RON, EkoEstMed, and ProModell focus on AI applications in medical imaging, precision medicine, and digital twins.

Differentiator

Problem solved

Functional benefit

Brands

• MIDIA-Hub: Digital Progress Hub focusing on implementation research and care integration
• DECIDE
• LeMeDaRT
• MiHUBx
• MiHUB

Products and services

• Data Integration Centers (DIZ) Site-level federated research-data infrastructure deployed at German university hospitals that captures routine clinical data, normalizes it via FHIR/i2b2/OMOP/GeMTeX, enforces Broad Consent governance, and exposes it to approved researchers through federated analytics, supporting MII use cases across MIRACUM's participating sites.
• FDPG National Research Data Portal Central, MII-wide research data portal co-developed with DIFUTURE that lets approved researchers query and request clinical data items across all German university hospitals in a standardized way; replaces the earlier MIRACUM Forschungsportal as the national access point for MIRACUM and DIFUTURE-affiliated sites.
• MIRACOLIX-Tools Software tool suite for federated analysis and clinical decision support within the DIZ network, used by MIRACUM researchers and use-case teams to run analyses and train models without moving patient-level data.
• Digital Progress Hubs (DECIDE, LeMeDaRT, MIDIA-Hub, MiHUBx) Four BMBF-funded Digital Progress Hubs inside MIRACUM (DECIDE, LeMeDaRT, MIDIA-Hub, MiHUBx) that extend DIZ-built federated infrastructure and AI models into regional / non-university healthcare settings and coordinate change-management with healthcare, patient and industry partners.
• Master BIDS Degree Programme Graduate-level degree programme (Master BIDS / Biomedical Data Science) developed with MIRACUM participation to train the medical-informatics workforce needed to operate and use the DIZ network, FDPG and MIRACOLIX-Tools.
• MIRACUM Schools (Summer and Winter) Recurring short-course / teaching programmes (Summer and Winter Schools) run by MIRACUM for medical-informatics students, clinicians and researchers, covering MIRACUM tools, MII methods and federated analysis techniques.

Quantifiable outcome

• More than 2 billion laboratory values, data from over 21 million patients, and more than 200 million vital data points from intensive care available for research through FDPG.
• +5 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability10 records

Feature8 records

Partnerships

14 partnerships are on record, tiered major, core and minor.

• Washington University in St. LouismajorStrategic or Co-development Partner · 1 May 2026Washington University in St. Louis collaborated on the Nature Biomedical Engineering publication on transcutaneous spinal cord stimulation. The partner group conducted electrophysiological investigations while Erlangen developed digital twins and simulations. Collaboration also involves Medizinische Universität Wien.
• Medizinische Universität WienmajorStrategic or Co-development Partner · 1 May 2026Medizinische Universität Wien partnered on the transcutaneous spinal cord stimulation study (Nature Biomedical Engineering), contributing electrophysiological investigations alongside Washington University in St. Louis and the Erlangen team.
• CAEHR and LeMeDaRT (DigiHubs)coreStrategic or Co-development Partner · 1 February 2026MIDIA-Hub collaborates with other Digital Progress Hubs CAEHR and LeMeDaRT on cross-hub use cases, particularly in gynecological oncology and perioperative care (e.g., ERAS protocols), sharing interfaces and aligning development roadmaps.
• Columbia University Irving Medical Center – Dept. of Biomedical InformaticsmajorStrategic or Co-development Partner · 1 November 2023As part of the 2023 USA Tour, MIRACUM-DIFUTURE visited Columbia University, where George Hripcsak hosted the delegation. Discussions focused on OHDSI (Observational Health Data Sciences and Informatics) collaboration, i2b2, and cross-institutional data sharing methodologies.
• Vanderbilt University – Dept. of Biomedical InformaticsmajorStrategic or Co-development Partner · 1 November 2023Vanderbilt University hosted MIRACUM-DIFUTURE during the 2023 USA Tour, with presentations by Peter Embi, Josh Peterson, Adam Wright and others. The Vanderbilt team presented their research foci, and MIRACUM-DIFUTURE shared MII results in a lunch seminar.
• Harvard University – Dept. of Biomedical InformaticsmajorStrategic or Co-development Partner · 1 November 2023Two visits to Harvard Medical School during the 2023 USA Tour: first meeting with Nils Gehlenborg on oncological patient data visualizations, and second with Shawn Murphy on the Research Patient Data Registry. Harvard is a key reference institution for MIRACUM's data infrastructure design.
• Yale School of Medicine – Dept. of Biomedical Informatics & Data SciencemajorStrategic or Co-development Partner · 1 November 2023Lucila Ohno-Machado (Chair of Biomedical Informatics & Data Science at Yale) organized a mini-symposium for the MIRACUM-DIFUTURE delegation. She is a member of the joint ISAB. The symposium addressed cross-site data use challenges and explored international exchange of master students and post-docs.
• AMIA (American Medical Informatics Association)majorStrategic or Co-development Partner · 1 November 2023MIRACUM-DIFUTURE participated in the five-day AMIA Symposium in New Orleans, the largest US medical informatics conference. The group held meetings with OHDSI Board of Directors and MII Advisory Board members (Lucila Ohno-Machado, Jim Cimino) during the event.
• OHDSI (Observational Health Data Sciences and Informatics)majorTechnology or Integration · 1 November 2023OHDSI is an international collaborative that develops methodologies for large-scale analytics of health data. MIRACUM-DIFUTURE engages with OHDSI for international data sharing standards, with George Hripcsak (Columbia) serving as a key connection point. Dr. Ines Reinecke leads Germany's role in the OHDSI community.
• SPHN (Swiss Personalized Health Network)majorStrategic or Co-development Partner · 1 November 2023Swiss counterpart to the MII, facing similar challenges. Dr. Katrin Crameri (SPHN member) gave a keynote at the MII Symposium 2022 on FAIR clinical data. A joint workshop on MII, SPHN & Health-RI produced a whitepaper on transnational health research in the European Health Data Space.
• Deutsche GlasfaserminorStrategic or Co-development Partner · 1 November 2023Deutsche Glasfaser co-organized the 'Digitale Orte 2023' competition with 'Deutschland – Land der Ideen'. DECIDE, the Digital Progress Hub, was selected as the winner in the Health category. Andreas Pfisterer (CEO Deutsche Glasfaser) participated in the award ceremony.
• DIFUTURE (Data Integration for Future Medicine)coreStrategic or Co-development Partner · 31 January 2023MIRACUM and DIFUTURE signed a cooperation agreement on January 31, 2023, to deepen collaboration between the two MII consortia. The agreement covers coordination of the 17 shared DIZ, joint education (Summer/Winter Schools, MIRACUM-DIFUTURE Kolloquium), cross-consortium research projects, patient involvement in DIZ governance, and joint public relations (MIRACUM-DIFUTURE Journal and annual joint symposia). Prof. Hans-Ulrich Prokosch (MIRACUM) and Prof. Martin Boeker (DIFUTURE) serve as consortium spokespersons.
• International Scientific Advisory Board (ISAB) – Joint MIRACUM & DIFUTUREmajorStrategic or Co-development Partner · 1 January 2023The joint ISAB includes internationally renowned experts: Lucila Ohno-Machado (Yale School of Medicine), Shawn Murphy (Harvard/University of Washington), Bradley Malin (Vanderbilt), Katrin Crameri (Swiss Federal Office of Public Health / SPHN), Jim Cimino, and others. The board meets annually to advise on consortium strategy.
• TMF (Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V.)coreImplementation/ SI/ Consulting Partner · 1 August 2016TMF operates the national MII coordination office (jointly with MFT and VUD) and the Forschungsdatenportal für Gesundheit (FDPG). TMF serves as the national coordination body and portal operator for the entire MII.

Scale indicators14 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Flatiron Health: US-based clinical data platform focused on oncology real-world data, acquired by Roche. Comparable in providing harmonized EHR data for research but operates on a commercial SaaS model with pharma industry contracts rather than public funding.
• TriNetX: Global commercial health data network offering federated clinical trial feasibility and real-world evidence. Has initiated a networking project with VUD (German university hospital directors), positioning it as a commercial alternative to MIRACUM's academic infrastructure for industry-sponsored research.

Direct peers

• NUM (Netzwerk Universitätsmedizin): German university medicine network initially created for COVID-19 coordination, now evolved into broader research infrastructure. Overlapping institutional base with MIRACUM (German university hospitals) and complementary mission for coordinated clinical research data sharing.
• SMITH Consortium: Fourth MII consortium focusing on university hospitals in eastern and western Germany. Same BMBF funding model, similar DIZ infrastructure goals, and shared FDPG integration. Competes with MIRACUM for the same university medical centers and federal research funding.
• HiGHmed (HiGHmed Medical Informatics Consortium): Another of the four MII consortia covering northern and central German university hospitals. Directly comparable in mission (Data Integration Centers, FHIR-based interoperability) and structure (multi-site university medicine consortium funded by BMBF).
• OHDSI (Observational Health Data Sciences and Informatics): International collaborative developing the OMOP common data model that MIRACUM uses at its DIZ sites. Direct methodological peer for federated clinical data analytics; MIRACUM-DIFUTURE engages with OHDSI Board of Directors and George Hripcsak (Columbia) leads cross-Atlantic collaboration.
• SPHN (Swiss Personalized Health Network): Swiss national initiative for clinical research data infrastructure, analogous to German MII. Co-developer of joint whitepaper on transnational health research in the European Health Data Space; Dr. Katrin Crameri (SPHN) sits on MIRACUM-DIFUTURE ISAB.
• Health-RI (Netherlands): Dutch national initiative for integrated health data infrastructure, comparable in mission and structure to MIRACUM. Partner in joint MII/SPHN/Health-RI whitepaper on European Health Data Space, making it a direct peer for cross-border federated research infrastructure.
• DIFUTURE (Data Integration for Future Medicine): Other MII consortium covering primarily Bavarian and southern German university hospitals. Direct peer operating Data Integration Centers on the same FDPG infrastructure with a formal cooperation agreement (Jan 2023) including joint symposia, education, and shared DIZ governance.

Emerging players

• i2b2 tranSMART Foundation: Academic open-source clinical research informatics platform (i2b2) that MIRACUM explicitly uses at its DIZ sites for cohort discovery. Methodological peer for federated query infrastructure; provides underlying technology that MIRACUM has adopted and extended.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCT6mS4rlAFLxaloaaVeJuFw/featured
• LinkedInlinkedin.com/company/miracum-konsortium
• Xx.com/MIRACUM_de

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MIRACUM Konsortium